Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 473

Related Articles by Review for PubMed (Select 16424172)

2.

Cell-based vaccines for the stimulation of immunity to metastatic cancers.

Ostrand-Rosenberg S, Pulaski BA, Clements VK, Qi L, Pipeling MR, Hanyok LA.

Immunol Rev. 1999 Aug;170:101-14. Review.

PMID:
10566145
4.

Genetic approaches for the induction of a CD4+ T cell response in cancer immunotherapy.

Bonehill A, Heirman C, Thielemans K.

J Gene Med. 2005 Jun;7(6):686-95. Review.

PMID:
15693037
5.

Dendritic cells, interleukin 12, and CD4+ lymphocytes in the initiation of class I-restricted reactivity to a tumor/self peptide.

Grohmann U, Fioretti MC, Bianchi R, Belladonna ML, Ayroldi E, Surace D, Silla S, Puccetti P.

Crit Rev Immunol. 1998;18(1-2):87-98. Review.

PMID:
9419451
6.

Direct identification of human tumor-associated peptide antigens and a preclinical model to evaluate their use.

Engelhard VH, Bullock TN, Colella TA, Mullins DW.

Cancer J. 2000 May;6 Suppl 3:S272-80. Review.

PMID:
10874498
7.

Tumor antigen presentation: changing the rules.

Armstrong TD, Pulaski BA, Ostrand-Rosenberg S.

Cancer Immunol Immunother. 1998 Apr;46(2):70-4. Review.

PMID:
9558001
9.
10.

CD4+ T-cell activation for immunotherapy of malignancies using Ii-Key/MHC class II epitope hybrid vaccines.

Xu M, Kallinteris NL, von Hofe E.

Vaccine. 2012 Apr 16;30(18):2805-10. doi: 10.1016/j.vaccine.2012.02.031. Epub 2012 Mar 3. Review.

PMID:
22386748
11.
12.

Antigen presentation in vaccine development.

Takahashi H.

Comp Immunol Microbiol Infect Dis. 2003 Oct;26(5-6):309-28. Review.

PMID:
12818619
13.

Control of MHC class II antigen presentation in dendritic cells: a balance between creative and destructive forces.

Villadangos JA, Schnorrer P, Wilson NS.

Immunol Rev. 2005 Oct;207:191-205. Review.

PMID:
16181337
14.

DM and DO shape the repertoire of peptide-MHC-class-II complexes.

Karlsson L.

Curr Opin Immunol. 2005 Feb;17(1):65-70. Review.

PMID:
15653313
15.

Immunotherapy in multiple myeloma: Id-specific strategies suggested by studies in animal models.

Corthay A, Lundin KU, Munthe LA, Fr√łyland M, Gedde-Dahl T, Dembic Z, Bogen B.

Cancer Immunol Immunother. 2004 Sep;53(9):759-69. Epub 2004 Apr 15. Review.

PMID:
15088126
16.
17.

The processing of antigens delivered as DNA vaccines.

Howarth M, Elliott T.

Immunol Rev. 2004 Jun;199:27-39. Review.

PMID:
15233724
18.

Antigen presentation to naive CD4 T cells in the lymph node.

Itano AA, Jenkins MK.

Nat Immunol. 2003 Aug;4(8):733-9. Review.

PMID:
12888794
19.

HLA-DM and the MHC class II antigen presentation pathway.

Jensen PE, Weber DA, Thayer WP, Chen X, Dao CT.

Immunol Res. 1999;20(3):195-205. Review.

PMID:
10741860
20.

Liposomal delivery of CTL epitopes to dendritic cells.

Chikh G, Schutze-Redelmeier MP.

Biosci Rep. 2002 Apr;22(2):339-53. Review.

PMID:
12428909
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk